Selling ARK (ARKK) & Buying AXS Short Innovation (SARK) ETF.
Going Short the Market. No Long Dissertation, No Rush. Market Risk Has Appeared, With Minimal Upside, So Time To Act.
Whitepaper: Effects of Magnetic Fields on Biological Systems
CLICK TO VIEW
EMULATE THERAPEUTICS
Jose Manuel Calderon Joins Hapbee (HAPB).
Prominent athlete participates in Private Placement and will contribute to Hapbee's expansion in global sports.
Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.
If we average out the two most recent price targets this month, we come out with a potential gain of 337% and...
Beyonce Tells Uber “Pay me in Stock!”
We all know Beyoncé is brilliant, but this move she made in 2015 may be the absolute ultimate in future planning. Four...
Premier Health (PHGRF) Announces Definitive Agreement to Acquire Livecare.
Livecare is an established leader in the Canadian digital health spaceHave provided over 27,000 telemedicine visitsService over 500 independent active health practitioner...
ChatGPT: Write a Song About Wall Street Using Style of Michael Jackson, Frank Sinatra..
...Snoop Dog, Elton John, Whitney Houston and Bruce Springsteen.
Write a song about the stock market using Michael...
EyeOnChannel.com
Eye on Channel is a digital video giant that connects millions of viewers to targeted and preferred demographics in destinations including Boston,...
Former Tesla Foundation Vice Chairman Joins StHealth BDC.
St Health Capital Investment Corporation is delighted to announce Dr. Robert GW Brown FAPS, FIEE, FInstP, MAE as a key new member to our board...
True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.
Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
